title: Gender difference in platelet aggregation and reactivity induced by recombinant human erythropoietin.
authors.affiliation: Section of Cell Aging and Gender Medicine.
authors.forename: Lucrezia
authors.initials: L
authors.lastname: Gambardella
authors.affiliation: Section of Cell Aging and Gender Medicine.
authors.forename: Rosa
authors.initials: R
authors.lastname: Vona
authors.affiliation: Drug Abuse and Doping Unit, Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, 00161, Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Pichini
authors.affiliation: Drug Abuse and Doping Unit, Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, 00161, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Pacifici
authors.affiliation: Section of Cell Aging and Gender Medicine.
authors.forename: Walter
authors.initials: W
authors.lastname: Malorni
authors.affiliation: Section of Cell Aging and Gender Medicine.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Straface
mesh_terms: D015331:Cohort Studies; D004300:Doping in Sports; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D058573:Performance-Enhancing Substances / Q000008:administration & dosage / Q000009:adverse effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012727:Sex Characteristics; D055815:Young Adult
chemical_list: C554270:EPO protein, human; D058573:Performance-Enhancing Substances; D011994:Recombinant Proteins; D004921:Erythropoietin